Enzymatic Stereoselective Ring-Opening for Pregabalin Intermediate

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for preparing pregabalin chiral intermediate (R)-3-(carbamoylmethyl)-5-methylhexanoic acid involve racemate resolution steps, which are costly, inefficient, and environmentally unfriendly, and result in low optical purity.

Innovation Solution

A method involving the stereoselective ring-opening of 3-isobutylglutarimide under biological enzymatic catalysis to directly obtain (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, eliminating the need for racemate resolution and incorporating immobilized enzymes for high optical purity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If racemate resolution steps are used to prepare (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, then the chiral intermediate can be obtained, but the production cost increases and efficiency decreases

Engineering Contradiction:

Improveoptical purityVSAvoidproduction efficiency

Core Design Contradiction:

Manufacturing precisionVSProductivity

Solution Approach 1:

The patent replaces traditional chemical resolution methods with biological enzymatic catalysis. Specifically, it uses lipase or esterase enzymes to achieve stereoselective ring-opening of 3-isobutylglutarimide, directly producing the desired (R)-enantiomer with high optical purity while eliminating the need for costly and inefficient racemate resolution steps

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the reaction conditions by using mild enzymatic catalysis instead of harsh chemical reagents. The reaction is conducted at lower temperatures (25-50°C) and neutral pH conditions, which not only improves selectivity for the desired enantiomer but also enhances overall reaction efficiency and reduces byproduct formation

Inventive Principle:

Principle #35Parameter changes

2Reliability

If traditional chemical synthesis methods are used, then the synthesis route is established, but the process route becomes long and production cost increases

Engineering Contradiction:

Improvesynthesis route stabilityVSAvoidprocess route complexity

Core Design Contradiction:

ReliabilityVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the unnecessary racemate resolution step from the traditional synthesis route. By using stereoselective enzymatic catalysis to directly produce the (R)-enantiomer from 3-isobutylglutarimide, the method removes the intermediate steps of producing racemate followed by resolution, thereby shortening the overall process route and reducing complexity

Inventive Principle:

Principle #2Taking out (Extraction)

Solution Approach 2:

The patent segments the synthesis into two clear stages: first preparing 3-isobutylglutarimide from 3-isobutylglutaric acid, then performing stereoselective ring-opening with enzymatic catalysis to obtain the chiral intermediate. This segmentation makes the process more controllable and easier to optimize at each stage

Inventive Principle:

Principle #1Segmentation

3Manufacturing precision

If racemate resolution is performed to obtain (R)-3-(carbamoylmethyl)-5-methylhexanoic acid, then the chiral intermediate is obtained, but environmental pollution increases

Engineering Contradiction:

Improveoptical purityVSAvoidenvironmental pollution

Core Design Contradiction:

Manufacturing precisionVSObject-generated harmful factors

Solution Approach 1:

The patent replaces traditional chemical resolution methods that generate harmful waste with biological enzymatic catalysis. The use of lipase or esterase enzymes under mild conditions eliminates the need for harsh chemicals and reduces environmental pollution while maintaining high optical purity of the product

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent converts the potential harm of complex chemical synthesis into benefit by using biodegradable enzymes as catalysts. The enzymatic process operates under mild conditions, produces minimal waste, and the enzymes themselves are environmentally benign, thereby converting what could be a harmful chemical process into an eco-friendly biological process

Inventive Principle:

Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method reduces production costs, shortens the process route, enhances efficiency, and achieves high optical purity, making it suitable for industrial production and providing high-quality raw materials for pregabalin synthesis.

Implementation Method 1

performing stereoselective ring-opening of 3-isobutylglutarimide under the catalysis of a biological enzyme to directly obtain the chiral intermediate (R)-3-(carbamoylmethyl)-5-methylhexanoic acid

Methodology Applied

Scientific EffectEnzymatic catalysis: Enzyme

Data Source

PatentUS11420932B2Method for preparing pregabalin intermediate (R)-3-(carbamoylmethyl)-5-methylhexanoic acid

Publication Date: 2022.08.23 ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD

AI summary

A method for preparing pregabalin chiral intermediate (R)-3-(carbamoylmethyl)-5-methylhexanoic acid by a biological enzyme method. In particular, the method comprises: reacting compound (I) 3-isobutylglutaric acid, as a raw material, with a nitrogen-containing agent to produce compound (II) 3-isobutylglutarimide; and performing stereoselective ring-opening of compound (II) under the action of a biological enzyme to produce compound (III) (R)-3-(carbamoylmethyl)-5-methylhexanoic acid: